Document:

Exhibit 10.5

 

Loans Extension Confirmation Letter

 

Reference is made to
the loans from Ms. Heung Mei Tsui to China Pharma Holdings, Inc. (the “Company”), the principal and accumulated interest
totaled USD1,354,567 and USD111,940.95 respectively as of December 31, 2019. Due to the fact the Company temporarily did not have
enough balance in its oversea account to repay the loans, both Ms. Tsui and the Company agreed to extend the loans to December
31, 2020, by which date the Company shall repay the principal and accumulated interest.

 

	 	Lender: 	/s/ Heung Mei Tsui

 

	 	Borrower:	China Pharma Holdings, Inc.

 

	 	By:	/s/ Zhilin Li, President & CEOcvgw_Ex4_1

		
			Exhibit 4.1
		

		
			DESCRIPTION OF THE SECURITIES OF CALAVO GROWERS, INC. REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934
		

		
			Calavo Growers, Inc. (“Calavo,” “we,” “our,” and “us”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended: our common stock, par value $0.001 per share (the “common stock”).
		

		
			The following description of our common stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to (1) our Articles of Incorporation, as amended (the “Articles of Incorporation”), and (2) our Amended and Restated Bylaws (the “Bylaws”), each of which is filed as an exhibit to our Annual Report on Form 10‐K, as amended, of which this Exhibit 4.1 is a part. We encourage you to read the Articles of Incorporation and the Bylaws, as well as the applicable provisions of the California General Corporation Law, for additional information.
		

		
			We have authority to issue 100,000,000 shares of common stock. As of January 31, 2020, 17,614,233 shares of our common stock were issued and outstanding, all of which are fully paid and nonassessable.
		

		
			We have one class of common stock. Holders of our common stock are entitled to one vote per share on all matters to be voted upon by shareholders, provided that shareholders have cumulative voting rights in the election of directors. Holders of shares of common stock are entitled to receive on a pro rata basis such dividends, if any, as may be declared from time to time by our board of directors in its discretion from funds legally available for that use. They are also entitled to share on a pro rata basis in any distribution to shareholders upon our liquidation, dissolution or winding up. Common shareholders do not have preemptive rights to subscribe to any additional stock issuances by us, and they do not have the right to require the redemption of their shares or the conversion of their shares into any other class of our stock.
		

		
			The following provisions of our Bylaws may have the effect of discouraging, delaying or preventing someone from acquiring us or merging with us, which might cause the market price of our common stock to decline or prevent shareholders from realizing a premium over the market price of their shares:
		

			
	
			
				 ·
			

			
	
			
			Our Bylaws establish advance notice procedures with respect to the nomination of candidates for election as directors and the proposal of other business for consideration at shareholders’ meetings, other than nominations or proposals made by or at the direction of the board of directors or a committee of the board of directors;

			
	
			
				 ·
			

			
	
			
			Within the range specified by our Bylaws, our board of directors determines the size of our board and may create new directorships and elect new directors, which may enable an incumbent board to maintain control by adding directors; and

			
	
			
				 ·
			

			
	
			
			Our board of directors may amend our Bylaws without a vote of our shareholders, which may enable our board to change our Bylaws to deter a proxy contest in connection with an unsolicited takeover offer.

		
			The transfer agent and registrar of our common stock is Computershare Trust Company, N.A.; P.O. Box 505000, Louisville, Kentucky 40233-5000. Its telephone number is (800) 962‐4284.
		

		
			Our common stock is traded on the NASDAQ Global Select Market under the symbol “CVGW.”
		

		 

		

			1EX-10.15

 Exhibit 10.15 

AMENDMENT TO 

STOCKHOLDERS’ AGREEMENT 

This Amendment (this “Amendment”) to the Stockholders’ Agreement, dated as of December 19, 2019 (the
“Agreement”), by and among KLDiscovery, Inc. (formerly known as Pivotal Acquisition Corp.), a Delaware corporation (the “Company”), CEOF II DE I AIV, L.P., a Delaware limited partnership (“CEOF
AIV”), CEOF II Coinvestment (DE), L.P., a Delaware limited partnership (“CEOF Coinvest”), CEOF II Coinvestment B (DE), L.P., a Delaware limited partnership (“CEOF Coinvest B”), and Revolution Growth III,
LP, a Delaware limited partnership (“Revolution” and, together with CEOF AIV, CEOF Coinvest and CEOF Coinvest B, the “LD Topco Holders”), is entered into as of March 23, 2020 (the “Amendment Date”),
by and among the Company and the LD Topco Holders. All capitalized terms used in this Amendment and not otherwise defined herein shall have the respective meanings given to such terms in the Agreement. 

RECITALS 
 WHEREAS, the
parties to the Agreement desire to amend the Agreement as expressly provided in this Amendment pursuant to Section 16 of the Agreement. 

NOW, THEREFORE, in consideration of the covenants, promises and representations set forth herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows; 

1.    Amendment to Section 1(b). Section 1(b) of the Agreement is hereby amended and
restated in its entirety and replaced for all purposes of the Agreement with the following (with deletions to the prior text shown in strikethrough, and additions shown with bold underline): 

The Company shall take all necessary and desirable actions within its controlhas taken
actions such that, as of the Effective Timeas of the Amendment Date: (i) the size of the Board shall beis set at eightnine
members; and (ii) the following persons shall form the composition of the Board: (A) Richard J. Williams, Lawrence Prior and Kevin Griffin shall be appointedare
serving as Class A Directors with terms ending at the Company’s 2020 Annual Meeting; (B) Donna Morea, Jonathan J. Ledecky and Evan Morgan shall be appointedare serving as Class B
Directors with terms ending at the Company’s 2021 Annual Meeting; and (C) Christopher J. Weiler, Daniel F. AkersonIan Fujiyama and William Darman shall be appointedare
serving as Class C Directors with terms ending at the Company’s 2022 Annual Meeting. 

2.    Amendment to Section 1(c). Section 1(c) of the Agreement is hereby amended and
restated in its entirety and replaced for all purposes of the Agreement with the following (with deletions to the prior text shown in strikethrough, and additions shown with bold underline): 

 

	 	(c)	 Subject to the terms and conditions of this Agreement, from and after the Effective Time
and until a Termination Event shall have occurred, the Company shall, as promptly as practicable, take all necessary and desirable actions within its control (including, without limitation, calling special meetings of the Board and the
shareholders and recommending, supporting and soliciting proxies), so that: 

	 	(i)	 for so long as the LD Topco Holders (together with their Affiliates) Beneficially Own a number of shares of
Common Stock equal to or greater than 65% of the total number of shares of Common Stock acquired by the LD Topco Holders on the date hereof, the LD Topco Holders holding a majority of the LD Topco Shares shall have the right to nominate, in the
aggregate, a number of Nominees equal to six (less the number of LD Topco Directors who are not up for election), and the size of the Board shall be set at eightnine members; 

 

	 	(ii)	 for so long as the LD Topco Holders (together with their Affiliates) Beneficially Own a number of shares of
Common Stock equal to or greater than 35% of the total number of shares of Common Stock acquired by the LD Topco Holders on the date hereof, but less than 65% of the total number of shares of Common Stock acquired by the LD Topco Holders on the date
hereof, the LD Topco Holders holding a majority of the LD Topco Shares shall have the right to nominate, in the aggregate, a number of Nominees equal to three (less the number of LD Topco Directors who are then serving but not up for election), and
the size of the Board shall be set at eightnine members; and 

  

	 	(iii)	 for so long as the LD Topco Holders (together with their Affiliates) Beneficially Own a number of shares of
Common Stock equal to or greater than 10% of the total number of shares of Common Stock acquired by the LD Topco Holders on the date hereof but less than 35% of the total number of shares of Common Stock acquired by the LD Topco Holders on the date
hereof, the LD Topco Holders holding a majority of the LD Topco Shares shall have the right to nominate, in the aggregate, a number of Nominees equal to one (less the number of LD Topco Directors who are then serving but not up for election), and
the size of the Board shall be set at eightnine members; 

 provided, that,
no reduction in the number of shares of Common Stock over which the LD Topco Holders and their Affiliates retain voting control shall shorten the term of any incumbent Director. 

3.    LD Topco Holders Approval. The LD Topco Holders hereby consent to the actions taken by the Company to
increase the size of the Board as contemplated in this Amendment. For the avoidance of doubt, as of the Amendment Date, (a) the LD Topco Holders have not designated any Nominee in connection with a stockholder meeting and (b) as a result,
no LD Topco Director yet exists. 
 4.    Remaining Provision; References. Except as expressly modified by this
Amendment, the Agreement shall remain in full force and effect. Each reference in the Agreement to “this Agreement,” “hereunder,” “hereof,” “herein” or words of like import referring to the Agreement, and each
reference in any other document relating to the “Agreement,” “thereunder,” “thereof” or words of like import referring to the Agreement, means and references the Agreement as amended by this Amendment. 

  
 2 

 5.    Miscellaneous. Sections 8 (No Strict Construction), 11
(Counterparts), 12 (Governing Law), 13 (Jurisdiction; WAIVER OF TRIAL BY JURY) and 16 (Amendment and Waiver) of the Agreement shall apply to this Amendment, mutatis mutandis. 

[Remainder of page intentionally left blank] 

  
 3 

 IN WITNESS WHEREOF, each of the parties hereto has caused this Amendment to be duly executed
as of the date first above written. 
  

			
	KLDISCOVERY, INC.
		
	By:	 	/s/ Dawn Wilson    
		 	Name: Dawn Wilson
		 	Title: CFO
	
	 CEOF II DE I AIV, L.P.
  

By: CEOF II DE AIV GP, L.P., its general partner
 By: CEOF II DE
GP AIV, L.L.C., its general partner

		
	By:	 	/s/ Will Darman    
		 	Name: Will Darman
		 	Title: Managing Director
	
	 CEOF II COINVESTMENT (DE), L.P.
  

By: CEOF II DE AIV GP, L.P., its general partner
 By: CEOF II DE
GP AIV, L.L.C., its general partner

		
	By:	 	/s/ Will Darman    
		 	Name: Will Darman
		 	Title: Managing Director
	
	 CEOF II COINVESTMENT B (DE), L.P.
  

By: CEOF II DE AIV GP, L.P., its general partner
 By: CEOF II DE
GP AIV, L.L.C., its general partner

		
	By:	 	/s/ Will Darman    
		 	Name: Will Darman
		 	Title: Managing Director

  
 [Signature Page to
Amendment to Stockholders Agreement] 

 
			
	 REVOLUTION GROWTH III, LP
  

By: Revolution Growth GP III, L.P., its general partner
 By:
Revolution Growth UGP III, LLC, its general partner

		
	By:	 	/s/ Steven J. Murray    
		 	Name: Steven J. Murray
		 	Title: Operating Manager

  
 [Signature Page to
Amendment to Stockholders Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]